Expression of interleukin 6 and its receptor in human gastric and colorectal cancers

Journal of International Medical Research

Volumn 31, Issue 2, 2003, Pages 69-75

  Matsuo, K ^a   Oka, M ^a   Murase, K ^a   Soda, H ^a   Isomoto, H ^a   Takeshima, F ^a   Mizuta, Y ^a   Murata, I ^b   Kohno, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Cytokine; Gastric cancer; Interleukin 6; Interleukin 6 receptor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER IMMUNOLOGY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION FUNCTION; GENE EXPRESSION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PLEIOTROPY; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 0038367744     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000303100202     Document Type: Article

References (28)

1. Sehgal PB, Grieninger G, Tosato G: Regulation of the acute phase and immune responses: interleukin-6. Ann N Y Acad Sci 1989; 557: 1-583.
2. Kishimoto T: The biology of interleukin-6. Blood 1989; 74: 1-10.
3. Beck JT, Hsu S-M, Wijdenes J, Bataille R, Klein B, Vesole D, et al: Alleviation of systematic manifestation of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994; 330: 602-605.
4. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, et al: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988; 18: 1797-1801.
5. Gaillard JP, Liautard J, Klein B, Brochier J: Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines. Eur J Immunol 1997; 27: 3332-3340.
6. Yawata H, Yasukawa K, Natsuka S, Murakami M, Yamasaki K, Hibi M, et al: Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J 1993; 12: 1705-1712.
7. Shabo Y, Lotem J, Sachs L: Autoregulation of interleukin-6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells. Mol Cell Biol 1989; 9: 4109-4112.
8. Klein B, Zhang X-G, Jourdan M, Content J, Houssiau F, Aarden L, et al: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517-526.
9. Takizawa H, Ohtoshi T, Ohta K, Yamashita N, Hirohata S, Hirai K, et al: Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Cancer Res 1993; 53: 4175-4181.
10. Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I: Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990; 50: 7786-7788.
11. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, et al: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83-85.
12. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992; 258: 593-597.
13. Baba M, Hasegawa H, Nakayabu M, Shimizu N, Suzuki S, Kamada N, et al: Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am J Hematol 1995; 49: 207-215.
14. Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H: Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 2000; 151: 31-38.
15. Piancatelli D, Romano P, Sebastiani P, Adorno D, Casciani CU: Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunother 1999; 22: 25-32.
16. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
17. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, et al: Complementary DNA for novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73-76.
18. Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Symann ML: Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in non-hematopoietic human malignant cell lines. Cancer Res 1993; 53: 3139-3144.
19. Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartzentruber DS, Ettinghausen SE, et al: Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 1993; 11: 499-506.
20. Gazdar AF, Minna JD: Targeted therapies for killing tumor cells. Proc Natl Acad Sci U S A 2001; 98: 10028-10030.
21. Hirano T, Akira S, Taga T, Kishimoto T: Biological and clinical aspect of interleukin 6. Immunol Today 1990; 11: 443-449.
22. Jernberg H, Pettersson M, Kishimoto T, Nilsson K: Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. Leukemia 1991; 5: 255-265.
23. Lopez M, Maroc N, Kerangueven F, Bardin F, Courcoul M, Lavezzi C, et al: Coexpression of gene for interleukin 6 and its receptor without apparent involvement in proliferation of acute myeloid leukemia cells. Exp Hematol 1991; 19: 797-803.
24. Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P'eng FK, et al: Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996; 91: 1417-1422.
25. Tran-Thang C, Kruithof EKO, Lahm H, Schuster WA, Tada M, Sordat B: Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Br J Cancer 1996; 74: 846-852.
26. De Vita F, Romano C, Orditura M, Galizia G, Martinelli E, Lieto E, et al: Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res 2001; 21: 45-52.
27. Nishimoto N, Ogata A, Shima Y, Tani Y, Ogawa H, Nakagawa M, et al: Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J Exp Med 1994; 179: 1343-1347.
28. Ohtani H, Sasano N: Stromal cell changes in human colorectal adenomas and carcinomas. An ultrastructural study of fibroblasts, myofibroblasts, and smooth muscle cells. Virchows Arch A Pathol Anat Histopathol 1983; 401: 209-222.